See analyst estimates and all valuation multiples for Building Products
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $104B | 2.8x | 13.7x | |
| $88.1B | 4.1x | 20.4x | |
| $77.2B | 3.2x | 18.9x | |
| $63.2B | 1.2x | 7.4x | |
| $58.3B | 2.7x | 15.2x | |
| $51.3B | 3.1x | 15.7x | |
| $46.1B | 7.0x | 20.5x | |
| $42.8B | 3.0x | 16.8x | |
| $38.2B | 2.9x | 19.3x | |
| $36.0B | 1.2x | 8.4x | |
| $35.2B | 4.0x | 26.3x | |
| $31.2B | 6.7x | 36.0x | |
| $28.7B | 1.7x | 16.5x | |
| $25.3B | 0.6x | 9.8x | |
| $24.5B | 1.5x | 7.8x | |
| $23.3B | 1.5x | 11.8x | |
| $19.9B | 3.8x | 17.2x | |
| $19.1B | 1.3x | 11.6x | |
| $18.6B | 3.9x | 13.1x | |
| $18.6B | 1.2x | 11.3x | |
| $18.0B | 1.7x | 12.8x | |
| $17.0B | 2.2x | 12.0x | |
| $16.6B | 3.3x | 13.7x | |
| $16.5B | 10.4x | 44.6x | |
| $15.4B | 1.5x | 6.7x | |
| $15.0B | 2.8x | 14.5x | |
| $14.7B | 3.2x | 17.2x | |
| $13.0B | 4.4x | 14.0x | |
| $12.8B | 9.2x | 37.9x | |
| $11.8B | 1.0x | 4.4x | |
| $10.6B | 4.7x | 20.9x | |
| $10.5B | 2.3x | 12.5x | |
| $10.3B | 2.3x | 14.9x | |
| $9.8B | 0.6x | 5.8x | |
| $9.6B | 2.1x | 10.5x | |
| $9.3B | 3.9x | 18.0x | |
| $9.1B | 5.5x | 16.2x | |
| $8.6B | 2.9x | 17.2x | |
| $8.2B | 2.6x | 6.0x | |
| $7.6B | 2.2x | 16.5x | |
| $7.2B | 5.2x | 29.7x | |
| $7.0B | 1.6x | 7.0x | |
| $6.9B | 1.1x | 11.5x | |
| $6.8B | 2.4x | 11.8x | |
| $6.8B | n/a | n/a | |
| $6.5B | 2.4x | 15.2x | |
| $5.9B | 1.1x | 6.7x | |
| $5.7B | 1.8x | 11.8x | |
| $5.5B | 1.4x | 12.0x | |
| $5.2B | 2.1x | 10.0x | |
| $4.9B | 2.1x | 10.4x | |
| $4.8B | 1.1x | 5.0x | |
| $4.6B | 4.0x | 14.0x | |
| $4.1B | 1.0x | 6.4x | |
| $4.0B | 2.8x | 12.0x | |
| $4.0B | 0.6x | 8.8x | |
| $3.8B | 0.4x | 10.1x | |
| $3.5B | 2.1x | 9.0x | |
| $3.4B | 1.3x | 9.7x | |
| $3.4B | n/a | n/a | |
| $2.7B | 1.7x | 9.8x | |
| $2.6B | 0.8x | 7.0x | |
| $2.5B | 1.8x | 9.2x | |
| $2.5B | 2.5x | 8.3x | |
| $2.2B | n/a | n/a | |
| $2.1B | n/a | n/a | |
| $2.1B | n/a | n/a | |
| $2.0B | 3.3x | 13.1x | |
| $2.0B | 1.4x | 9.0x | |
| $1.9B | 0.3x | 9.2x | |
| $1.6B | 0.9x | 6.5x | |
| $1.5B | 1.3x | 7.8x | |
| $1.5B | 0.5x | 13.0x | |
| $1.5B | 1.1x | 8.7x | |
| $1.4B | 1.6x | 8.1x | |
| $1.3B | 1.6x | 8.0x | |
| $1.2B | 0.8x | 6.5x | |
| $1.2B | 1.2x | 8.9x | |
| $1.2B | 0.4x | 1.5x | |
| $1.2B | n/a | n/a | |
| $1.1B | 1.6x | 11.1x | |
| $1.1B | 1.3x | 10.8x | |
| $1.1B | n/a | n/a | |
| $1.1B | 0.5x | 8.3x | |
| $1.0B | n/a | n/a | |
| $1.0B | 0.7x | 5.9x | |
| $986M | 1.5x | 12.2x | |
| $956M | 2.6x | 17.3x | |
| $900M | n/a | n/a | |
| $858M | 0.2x | 5.5x | |
| $789M | 0.4x | 5.5x | |
| $767M | 0.4x | 6.7x | |
| $743M | n/a | n/a | |
| $608M | 0.9x | 7.9x | |
| $593M | 0.8x | 9.6x | |
| $593M | 0.8x | 8.1x | |
| $568M | 1.4x | 6.2x | |
| $565M | 0.9x | 8.0x | |
| $500M | 0.6x | 4.0x | |
| $498M | 2.9x | 9.2x | |
| $488M | n/a | n/a | |
| $463M | 1.9x | 10.5x | |
| $461M | 0.4x | 5.2x | |
| $450M | 0.9x | 6.1x | |
| $414M | 1.6x | 17.9x | |
| $402M | n/a | n/a | |
| $401M | n/a | n/a | |
| $399M | 0.7x | 5.3x | |
| $396M | n/a | n/a | |
| $333M | 0.9x | 5.6x | |
| $328M | 1.7x | 5.9x | |
| $324M | 1.5x | 10.6x | |
| $306M | n/a | n/a | |
| $271M | n/a | n/a | |
| $253M | 0.6x | 5.7x | |
| $242M | n/a | n/a | |
| $234M | 0.6x | 8.2x | |
| $229M | -55.4x | -21.2x | |
| $229M | n/a | n/a | |
| $204M | n/a | n/a | |
| $182M | 0.3x | 4.3x | |
| $172M | 2.0x | 6.7x | |
| $143M | 0.4x | 3.7x | |
| $119M | n/a | n/a | |
| $114M | n/a | n/a | |
| $99.8M | n/a | n/a | |
| $99.3M | 0.9x | 7.8x | |
| $91.4M | n/a | n/a | |
| $90.6M | n/a | n/a | |
| $83.3M | n/a | n/a | |
| $62.8M | n/a | n/a | |
| $51.3M | n/a | n/a | |
| $50.3M | n/a | n/a | |
| $45.5M | 1.3x | 11.0x | |
| $33.7M | n/a | n/a | |
| $32.9M | 0.5x | -9.1x | |
| $30.6M | 0.5x | 6.7x | |
| $15.6M | n/a | n/a | |
| $14.9M | n/a | n/a | |
| $13.4M | n/a | n/a | |
| $13.4M | n/a | n/a | |
| $11.9M | 0.5x | -10.0x | |
| $9.6M | n/a | n/a | |
| $3.2M | n/a | n/a | |
| $0.3M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Building Products